LEXINGTON, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Needham 10th Annual Healthcare Conference at 11:20 a.m. EDT on April 5, 2011, in New York City.
